🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with coronary artery calcium score changes on glp-1? Page 5

Has anyone dealt with coronary artery calcium score changes on glp-1?

KarenAZ_mom Thu, Apr 4, 2024 at 11:16 PM 35 replies 2,233 viewsPage 5 of 7
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Apr 6, 2024 at 6:03 PM#21
wendy_avl said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my key markers:

Weight: consistent downtrend, -2.4 lbs/week average
Fasting glucose (finger stick): stable at 87 mg/dL
Blood pressure (home): 119/73 average
Resting heart rate: 67 bpm (down from 83)
Waist circumference: down 17 inches total

The resting heart rate improvement correlates with cardiovascular fitness gains. Everything is moving in the right direction.

16 14VendorMark, COA_Karl, MikeFit_NJ and 13 others
Reply Quote Save Share Report
emma_london
Member
312
1,456
Oct 2024
London, UK
Apr 7, 2024 at 4:47 AM#22
wendy_avl said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

Last edited: Apr 7, 2024 at 10:47 AM
17 15mike.trainer_LA, sarah_nash92, FitDadDave and 14 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Apr 7, 2024 at 3:31 PM#23

Clinical perspective, offered as context rather than as advice.

wendy_avl said:
...cardiovascular risk is just another fad...

I understand the skepticism — we've all seen "miracle" weight loss solutions come and go. But consider what makes GLP-1 agonists different:

  • Phase 3 RCTs with thousands of participants (not 20-person pilot studies)
  • Published in NEJM, JAMA, Lancet (not press releases)
  • Replicated across multiple independent research groups
  • Proven cardiovascular and renal benefits beyond weight loss
  • Biological mechanism fully characterized at the receptor level

This isn't a fad — it's a new drug class supported by the highest level of clinical evidence. The comparison to past fads is understandable but inappropriate.

18 16HPLC_Greg, LibrarianMeg, bri_stats and 15 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Apr 8, 2024 at 2:14 AM#24
newstart_MO said:
wendy_avl said: ...cardiovascular risk is just another fad...

Same pattern here, and in the same order. Posting only so the count is not one.

19 17NicoleRaleigh, james_edin, FranDenver and 16 others
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Apr 8, 2024 at 12:57 PM#25
newstart_MO said:
wendy_avl said: ...cardiovascular risk is just another fad...

6 month update on cardiovascular risk: down 45 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

Last edited: Apr 8, 2024 at 1:57 PM
20 18Dr.NateNeph, PharmD_Rodriguez, julia.endo and 17 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register